
Pliant Therapeutics, Inc.
PLRXNasdaqCIK 1746473HealthcareFiscal year ends Dec 31
Reports and events: 106 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-10-0316:53 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001746473-23-000062 |
| 2023-09-2607:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-241849 |
| 2023-08-0916:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001746473-23-000053 |
| 2023-08-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-23-000051 |
| 2023-06-0816:46 ET | 8-K | 5.07 Shareholder vote results | 0001746473-23-000036 |
| 2023-05-0916:14 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001746473-23-000031 |
| 2023-05-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-23-000029 |
| 2023-05-0106:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-128616 |
| 2023-04-2616:01 ET | DEF 14A | Proxy statement | 0001746473-23-000012 |
| 2023-03-0916:13 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001746473-23-000008 |
| 2023-03-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-23-000007 |
| 2023-03-0816:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-064549 |
| 2023-02-2316:07 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-23-046525 |
| 2023-01-2517:26 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-015276 |
| 2023-01-2316:21 ET | 8-K | 8.01 Other events | 0001193125-23-013173 |
| 2023-01-2307:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-012607 |
| 2023-01-0908:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-004216 |
| 2022-11-1816:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-289077 |
| 2022-11-0816:15 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001746473-22-000031 |
| 2022-11-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-22-000030 |
| 2022-09-1616:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-246364 |
| 2022-08-0816:11 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001746473-22-000027 |
| 2022-08-0816:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-22-000025 |
| 2022-07-1416:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-193726 |
| 2022-07-1107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-190873 |
| 2022-06-1716:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-176473 |
| 2022-05-2717:01 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001193125-22-162455 |
| 2022-05-0916:18 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001746473-22-000021 |
| 2022-05-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-22-000019 |
| 2022-05-0516:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-142365 |
| 2022-04-2906:05 ET | DEF 14A | Proxy statementPeriod 2022-06-16 | 0001140361-22-016716 |
| 2022-03-0117:26 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001193125-22-061695 |
| 2022-03-0121:33 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-22-000012 |
| 2022-03-0118:29 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001746473-22-000010 |
| 2022-02-2816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-22-000009 |
| 2022-01-1008:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-001029 |
| 2021-11-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-21-000025 |
| 2021-11-0916:10 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001746473-21-000023 |
| 2021-09-0707:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-266016 |
| 2021-08-0916:21 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001746473-21-000019 |
| 2021-08-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-21-000017 |
| 2021-07-0210:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001746473-21-000011 |
| 2021-05-1017:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001746473-21-000008 |
| 2021-05-1016:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-21-000005 |
| 2021-04-3015:37 ET | DEF 14A | Proxy statementPeriod 2021-06-29 | 0001140361-21-015256 |
| 2021-03-1616:25 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-013589 |
| 2021-03-1616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-013576 |
| 2021-01-1317:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-008213 |
| 2020-12-2106:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-322128 |
| 2020-11-1016:22 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-052990 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.